After a Chennai man claimed he suffered neurological and psychological side effects from receiving an injection of the Covid-19 Covishield vaccine during the human trial being conducted by the Serum Institute of India (SII), the company based in Pune said there was no correlation between the two. In a post …
Read More »Assessment of the Covishield trial incident in Chennai is likely to end soon, says ICMR chief scientist
New Delhi: The country’s central drug regulator is seized of the suspected serious adverse event (SAE) that occurred in Chennai last month during phase II / III trials of the Covishield Covid vaccine and a final and in-depth evaluation is likely to be completed soon. of the incident. said Dr. …
Read More »As the race for the virus vaccine heats up, IBS’s smear against the volunteer who brought the case worries experts
The Serum Institute of India has called the accusations made by a volunteer of the IBS vaccine candidate “malicious”. On November 21, a 40-year-old Chennai volunteer from vaccine candidate Covishield filed a lawsuit against IBS. The volunteer stated that there was no adverse reaction during the first 10 days after …
Read More »Serum Institute files 100 million rupee case after man says vaccine made him sick
The Covid vaccine, Covishield, will be produced in India by the Serum Institute (Representational) The Serum Institute of India has responded to the “malicious and misleading” allegations by preparing a Rs 100 million defamation lawsuit against a Covishield coronavirus vaccine trial participant who claimed to suffer a “virtual neurological collapse” …
Read More »Coronavirus | ‘Covishield’ vaccine volunteer sues Serum Institute of India, Oxford Group for ‘adverse reaction’
The 40-year-old man claims “adverse reaction”; the hospital panel says it is not due to ‘Covishield’. A 40-year-old volunteer from ‘Covishield’, the vaccine candidate being tested by the Pune-based Serum Institute of India (SII), has sued the company for ₹ 5 crore, claiming the vaccine triggered an adverse reaction, including …
Read More »In the process of requesting emergency use of ‘Covishield’ in the next 2 weeks, says CEO of Serum | India News
NEW DELHI: Serum Institute of India is in the process of applying for the emergency use authorization of Covishield in the next two weeks, CEO Adar Poonawalla said. After holding a review meeting on Saturday with the Prime Minister Narendra modiPoonawalla said: “All over the world, now everyone is dependent …
Read More »Prime Minister Modi will visit three cities tomorrow to review the development of the Covid-19 vaccine
New Delhi: Prime Minister Narendra Modi will embark on a three-city visit on Saturday to “personally review the development and manufacturing process of the (coronavirus) vaccine,” the Prime Minister’s Office said on Friday. He will visit the Zydus Biotech Park in Ahmedabad, Bharat Biotech in Hyderabad and the Serum Institute …
Read More »Prime Minister Modi will visit the Serum Institute of India in Pune on November 28
Prime Minister Narendra Modi will visit the Serum Institute of India (SII) on Saturday to see the production of the Covid-19 vaccine and the proposed distribution plan, a senior official confirmed Thursday. “We have received official confirmation on the Prime Minister’s visit to Pune on November 28. The Prime Minister …
Read More »Covid-19 vaccines will be available soon, how will India get to the last person?
NEW DELHI : By officially stating that no vaccine in history has developed as rapidly as the covid-19 vaccine, there is now a real risk that the poorest and most vulnerable will be trampled on in the vaccine stampede, the World Health Organization warned ( WHO). Tedros Adhanom Ghebreyesus, WHO …
Read More »Everything you need to know about the country’s first covid vaccine
Everyone seems delighted, but what is the good news? AstraZeneca and Oxford experimented with two different dosage regimens. One regimen demonstrated 90% efficacy when AZD1222 was administered as a half dose followed by a full dose one month later. The second regimen was 62% effective when two full doses were …
Read More »